|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 3/06 | (2006.01) |
| (11) | Number of the document | 2721065 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12727767.1 |
| Date of filing the European patent application | 2012-06-14 | |
| (97) | Date of publication of the European application | 2014-04-23 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-12 |
| (46) | Date of publication of the claims translation | 2018-12-10 |
| (86) | Number | PCT/US2012/042338 |
| Date | 2012-06-14 |
| (87) | Number | WO 2012/174178 |
| Date | 2012-12-20 |
| (30) | Number | Date | Country code |
| 201161498518 P | 2011-06-17 | US | |
| 201161578309 P | 2011-12-21 | US |
| (72) |
SLEEMAN, Mark, W., AU
GUSAROVA, Viktoria, US
MURPHY, Andrew, J., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai prieš ANGPTL3 ir jų panaudojimo būdai |
| ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 14 | 289.00 EUR |
| 2026-06-14 |